| 000 | 01701 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516080156.0 | ||
| 264 | 0 | _c20140210 | |
| 008 | 201402s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/j.1476-5381.2012.01903.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aYu, Shan-Shan | |
| 245 | 0 | 0 |
_aSirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cJan 2013 |
||
| 300 |
_a117-28 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAngiotensin II |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAorta, Abdominal _xdiagnostic imaging |
| 650 | 0 | 4 |
_aCardiomegaly _xchemically induced |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aConstriction, Pathologic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xmetabolism |
| 650 | 0 | 4 |
_aNAD _xmetabolism |
| 650 | 0 | 4 |
_aNF-kappa B _xantagonists & inhibitors |
| 650 | 0 | 4 | _aRNA Interference |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSirtuins _xgenetics |
| 650 | 0 | 4 |
_aTranscription, Genetic _xphysiology |
| 650 | 0 | 4 | _aUltrasonography |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aCai, Yi | |
| 700 | 1 | _aYe, Jian-Tao | |
| 700 | 1 | _aPi, Rong-Biao | |
| 700 | 1 | _aChen, Shao-Rui | |
| 700 | 1 | _aLiu, Pei-Qing | |
| 700 | 1 | _aShen, Xiao-Yan | |
| 700 | 1 | _aJi, Yong | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 168 _gno. 1 _gp. 117-28 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1476-5381.2012.01903.x _zAvailable from publisher's website |
| 999 |
_c21546043 _d21546043 |
||